This is mainly because miR-148a directly targets upstream regulators of NF-κB and STAT3 signaling, leading to the activation of NF-κB and STAT3 in macrophages and connective tissues, which affects the pathogenesis of colitis and colitis-associated tumor formation (33). The gene discussed is NFKB1; the disease is neoplasm.